Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06580743 · ClinicalTrials.gov registry record
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 52
- Enrollment target
NCT06580743 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 52 participants.
The verdict
NCT06580743 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Breast cancer is the second most common cancer in women. One in five women who have been treated for breast cancer develop lymphedema. Lymphedema is a very common result of breast cancer and its treatment. Lymphedema is the build-up of fluid in tissues, which results in tissue swelling. The lymph system is a network of lymph vessels, tissues, and organs that carry extra fluid from your cells/tissues throughout the body. If this lymph fluid is not able to flow in the body how it should, there will be swelling which can lead to lymphedema. It can be classified into stages 0 to 3 depending on the severity of the condition. Stages 0 and 1 are reversible, and through early diagnosis and treatment, the recovery to the normal volume and normal skin status of arms can be possible. On the other hand, stage 2 or higher is irreversible, and tissue fibrosis progresses and cannot return to normal skin; therefore, it is important to detect early and start treatment. This is an observational longitudinal study. Potential participants will be recruited for follow-up after breast cancer surgery. Only patients who fit the inclusion criteria will be considered for participation in the study and contacted by the healthcare provider. Standard of care will be used to guide any treatment needed by participants while they are part of the study.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06580743
The ClinicalTrials.gov registry entry for NCT06580743 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06580743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06580743 about?
NCT06580743 is a clinical study titled "Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer". Breast cancer is the second most common cancer in women. One in five women who have been treated for breast cancer develop lymphedema. Lymphedema is a very common result of breast cancer and its treatment. Lymphedema is the build-up of fluid in tissues, which results in tissue swelling. The lymph sy...
What is the current status of trial NCT06580743?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2024-06-12. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT06580743?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06580743?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.